MNG
ELV icon

Manning & Napier Group’s Elevance Health ELV Stock Holding History

Manning & Napier Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-911
Closed -$206K – 288
2020
Q1 		$206K Sell
911
-15
-2% -$4.09K ﹤0.01% 293
2019
Q4 		$279K Buy
+926
New +$255K ﹤0.01% 283

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Manning & Napier Group's ELV Position: Q2 2020 in Review

Manning & Napier Group sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 911 shares — an estimated $206K sold.

Manning & Napier Group first reported a position in ELV in Q4 2019 and held it in 2 quarters. The position peaked at $279K in Q4 2019. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • Manning & Napier Group reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • Manning & Napier Group sold 911 Elevance Health shares in Q2 2020, an estimated $206K.
  • Manning & Napier Group first reported a position in Elevance Health in Q4 2019 and held it in 2 quarters.
  • Manning & Napier Group's Elevance Health position peaked at $279K in Q4 2019.
  • 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Manning & Napier Group's 13F filing for Q2 2020, filed 10 Jul 2020.